dr. goy on the potential utility of btk inhibitors as maintenance in mcl
Published 4 years ago • 26 plays • Length 0:41Download video MP4
Download video MP3
Similar videos
-
1:13
dr. goy on research efforts with btk inhibitors in mcl
-
1:28
dr. goy on the evolution of treatment selection in mcl
-
1:02
dr. goy on the progression of mcl treatment
-
1:09
dr. cohen on the potential of btk inhibitors in frontline treatment of mcl
-
1:29
dr. wang on the benefit of btk inhibitors in mcl
-
1:05
dr. fenske on the utility of next-generation btk inhibitors in mcl
-
1:05
dr. goy on combinations with novel agents in relapsed/refractory mcl
-
0:55
dr. smith on safety profiles of btk inhibitors in mcl
-
1:36
dr. goy on immunotherapy in mantle cell lymphoma
-
1:21
dr. goy on approved agents in the treatment landscape of mcl
-
1:34
dr. goy on the evolution of treatment in mantle cell lymphoma
-
0:59
dr. goy on rituximab maintenance therapy for patients with mcl
-
0:44
dr. goy on takeaways in mantle cell lymphoma for the future
-
1:27
dr. goy on the role of immunotherapy in mantle cell lymphoma
-
1:29
dr. wang on the utility of car t-cell therapy in relapsed/refractory mcl
-
1:22
dr. goy on changing treatment landscape of mantle cell lymphoma
-
4:13
mcl: novel btk inhibitor combination strategies
-
1:08
dr. goy on advancements in relapse/refractory mantle cell lymphoma
-
1:35
dr. goy on prognostic markers in mantle cell lymphoma